Search Results

You are looking at 11 - 18 of 18 items for :

  • "renal cancer" x
  • All content x
Clear All

Treatment Approaches in Renal Cancer Global Evaluation Trial. J Clin Oncol. 2009; 27: 3312–3318. 11 Motzer RJ, Hutson TE, Tomczak P, et al. Overall survival and updated results for

Restricted access
Orvosi Hetilap
Authors: József Gábor Joó, Éva Csatlós, Réka Brubel, Attila Bokor, Csaba Karabélyos, and János Rigó jr.

leiomyomatosis, hereditary leiomyomatosis and renal cancer and fumarate hydratase deficiency. Hum. Mol. Genet., 2003, 12 (11), 1241–1252. Zavadil, J., Ye, H., Liu, Z., et al.: Profiling and functional analyses of microRNAs

Open access

, R., Glenn, L., Hoen, H., et al.: Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program. J. Immunother. Cancer, 2014, 2, 13

Open access

proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility. Cancer Res. 63, 6971–6983 (2003) Rogers M

Restricted access

prolonging the time to renal cancer surgery affect long-term cancer control: a systematic review of the literature. Can J Urol. 2006; 13 (Suppl 3): 54–61. 61 Bell D, Morash C

Restricted access
Acta Microbiologica et Immunologica Hungarica
Authors: Saeed Khalili, Abolfazl Jahangiri, Hojat Borna, Kobra Ahmadi Zanoos, and Jafar Amani

renal cancer antigen through post-translational protein splicing. Nature 427 , 252–256 (2004). Yang JC Immune recognition of a human renal cancer antigen through post

Restricted access
Acta Microbiologica et Immunologica Hungarica
Authors: J. C. Horvath, Andrea Horak, J. G. Sinkovics, Mary Pritchard, Stacia Pendleton, and Elizabeth Horvath

Kirchner, H. H., Anton, P., Atzpodien, J.: Adjuvant treatment of locally advanced renal cancer with autologous virus-modified tumor vaccine. World J Urol 13 , 171 (1995). Adjuvant treatment of locally advanced renal cancer with

Restricted access

L Haworth RM Sherry 2003 A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal

Restricted access